First test of new Cancer-Fighting antibody begins in patients

NCT ID NCT04958239

Summary

This is a first-in-human study to find a safe dose of a new immunotherapy drug called BI 765179 for adults with advanced solid tumors. In the first part, researchers will test the drug alone and combined with another immunotherapy (ezabenlimab). In the second part, they will test it combined with pembrolizumab for people with advanced head and neck cancer who haven't had prior treatment for their advanced disease. The goal is to see if these combinations can help the immune system fight the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AZ Groeninge

    Kortrijk, 8500, Belgium

  • Affiliated Cancer Hospital and Institute of Guangzhou Medical University

    Guangzhou, 510095, China

  • Aichi Cancer Center Hospital

    Aichi, Nagoya, 464-8681, Japan

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Austin Hospital

    Heidelberg, Victoria, 3084, Australia

  • Avera Cancer Institute

    Sioux Falls, South Dakota, 57105, United States

  • Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência

    São Paulo, 01321-001, Brazil

  • Beverly Hills Cancer Center

    Beverly Hills, California, 90211, United States

  • Border Cancer Hospital

    Albury, New South Wales, 2640, Australia

  • CHA Bundang Medical Center

    Seongnam, 13496, South Korea

  • CTR Georges-François Leclerc

    Dijon, 21079, France

  • Centro Oncologico Internacional

    Mexico City, 04700, Mexico

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Clínica Universidad de Navarra

    Pamplona, 31008, Spain

  • Edegem - UNIV UZ Antwerpen

    Edegem, 2650, Belgium

  • Erasmus Medisch Centrum-ROTTERDAM-50697

    Rotterdam, 3015 GD, Netherlands

  • Fujian Cancer Hospital

    Fuzhou, 350014, China

  • Fundación Santos y de la Garza Evia, I.B.P

    Monterrey, 66278, Mexico

  • Gachon University Gil Medical Center

    Incheon, 21565, South Korea

  • HOP Saint-André

    Bordeaux, 33075, France

  • Hospital Clínico San Carlos

    Madrid, 28040, Spain

  • Hospital Germans Trias i Pujol

    Badalona, 08916, Spain

  • Hospital Sírio Libanês-São Paulo-68088

    São Paulo, 01308050, Brazil

  • Hospital Universitari Vall D Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario Dr Jose Eleuterio Gonzalez

    Monterrey, 64460, Mexico

  • Hunan Province Tumor Hospital

    Changsha, 410013, China

  • ICESP - Instituto do Cancer do Estado de Sao Paulo

    São Paulo, 01246-000, Brazil

  • INS Cancérologie Ouest Saint-Herblain

    Saint-Herblain, 44805, France

  • Instituto Nacional de Cancerologia

    México, 14080, Mexico

  • Istituto Nazionale IRCCS Tumori Fondazione Pascale

    Napoli, 80131, Italy

  • Kanagawa Cancer Center

    Kanagawa, Yokohama, 241-8515, Japan

  • Kansai Medical University Hospital

    Osaka, Hirakata, 573-1191, Japan

  • Kinghorn Cancer Centre

    Darlinghurst, New South Wales, 2010, Australia

  • Klinikum Stuttgart

    Stuttgart, 70174, Germany

  • Martin-Luther-Universität Halle-Wittenberg

    Halle, 06120, Germany

  • Masaryk Memorial Cancer Institute

    Brno, 65653, Czechia

  • NEXT Oncology-San Antonio-65273

    San Antonio, Texas, 78229, United States

  • National Cancer Center Hospital East

    Chiba, Kashiwa, 277-8577, Japan

  • Osaka International Cancer Institute

    Osaka, Osaka, 541-8567, Japan

  • Shaare-Zedek Medical Center, Oncology Institute

    Jerusalem, 9103102, Israel

  • Sourasky Medical Center

    Tel Aviv, 6423906, Israel

  • The First Affiliated Hospital Of Bengbu Medical College

    Bengbu, 233004, China

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27514, United States

  • Townsville Hospital

    Douglas, Queensland, 4814, Australia

  • University of Arizona

    Tucson, Arizona, 85719, United States

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, 79106, Germany

  • VU University Medical Center

    Amsterdam, 1081HV, Netherlands

  • Wuhan Union Hospital

    Wuhan, 430022, China

Conditions

Explore the condition pages connected to this study.